NCT04496492View on ClinicalTrials.gov

Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 9, 2016

Primary Completion Date

February 9, 2016

Study Completion Date

July 6, 2017

Conditions

Breast Cancer

Interventions

DRUG

Tocotrienol

Tocotrienol 200 mg orally twice a day

Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale Tumori, Milan

All Listed Sponsors

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT04496492 - Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial. | Biotech Hunter | Biotech Hunter